Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, Takuya, Perez-Potti, André, Rivera-Ballesteros, Olga, Strålin, Kristoffer, Gorin, Jean-Baptiste, Olsson, Annika, Llewellyn-Lacey, Sian, Kamal, Habiba +70 more·2020·Cell
DOI 10.1016/j.cell.2020.08.017

Cited by (1,002)

Items 201–300 of 1,002

  1. Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
    N. Ahmad Aziz, Victor M. Corman, Antje K. C. Echterhoff, Marcel A. Müller, Anja M. Richter, Antonio Schmandke, Marie Luisa Schmidt, Thomas H. Schmidt, Folgerdiena M. de Vries, Christian Drosten et al. · 2021 · Nature Communications
  2. Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience
    Yael Peled, Eilon Ram, Ii Jacob Lavee I, Amit Segev, Shlomi Matezky, Anat Wieder-Finesod, Rebecca Halperin, Michal Mandelboim, Victoria Indenbaum, Itzchak Levy et al. · 2021 · The Journal of Heart and Lung Transplantation
  3. Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope
    Garry M. Dolton, Cristina Rius, Md Samiul Hasan, Aaron Wall, Barbara Szomolay, Enas M. Behiry, Thomas Whalley, Joel Southgate, Anna Fuller, Théo Morin et al. · 2022 · Cell
  4. The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
    Rosemary Jane Boyton, Daniel Martin Altmann · 2021 · Nature reviews. Immunology
  5. Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
    Song, Ge, He, Wan-ting, Callaghan, Sean, Anzanello, Fabio, Huang, Deli, Ricketts, James, Torres, Jonathan L., Beutler, Nathan, Peng, Linghang, Vargas, Sirena et al. · 2020
  6. Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations
    Bernhard Kratzer, Doris Trapin, Paul Ettel, Ulrike Körmöczi, Arno Rottal, Friedrich Tuppy, Melanie Feichter, Pia Gattinger, Kristina Borochova, Yulia Dorofeeva et al. · 2020 · Allergy
  7. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion
    Veronique R. Nussenblatt, Allison E. Roder, Sanchita Basu Das, Emmie de Wit, Jung-Ho Youn, Stephanie Banakis, Alexandra A. Mushegian, Christopher Mederos, Wei Wang, Matthew C. Chung et al. · 2021 · The Journal of Infectious Diseases
  8. B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
    Eva Vanessa Schrezenmeier, Héctor Rincón-Arévalo, Ana‐Luisa Stefanski, Alexander Potekhin, Henriette Straub-Hohenbleicher, Mira Choi, Friederike Bachmann, Vanessa Proß, Charlotte Hammett, Hubert Schrezenmeier et al. · 2021 · Journal of the American Society of Nephrology
  9. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
    Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, Amirhossein Nazerian, Seyyed Mahmoud Hashemi · 2022 · International Immunopharmacology
  10. SARS-CoV-2 responsive T cell numbers and anti-Spike IgG levels are both associated with protection from COVID-19: A prospective cohort study in keyworkers
    Wyllie, David, Jones, Hayley E, Mulchandani, Ranya, Trickey, Adam, Taylor-Phillips, Sian, Brooks, Tim, Charlett, Andre, Ades, AE, EDSAB-HOME investigators, Moore, Philippa et al. · 2020
  11. Covid-19: Do many people have pre-existing immunity?
    Peter Doshi · 2020 · BMJ
  12. The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient—A Case Study
    Chiara Sepulcri, Chiara Dentone, Małgorzata Mikulska, Bianca Marisa Bruzzone, Alessia Lai, Daniela Fenoglio, Federica Maria Bozzano, Annalisa Bergna, Alessia Parodi, Tiziana Altosole et al. · 2021 · Open Forum Infectious Diseases
  13. Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment
    Nicolas Ripari, Arthur Alves Sartori, Mariana da Silva Honorio, Fernanda Lopes Conte, Karen Ingrid Tasca, Karina Basso Santiago, José Maurício Sforcin · 2021 · Journal of Pharmacy and Pharmacology
  14. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
    Jason A. Neidleman, Xiaoyu Luo, Ashley F. George, Matthew M. McGregor, Junkai Yang, Cassandra A. Yun, Victoria Murray, Gurjot Gill, Warner C. Greene, Joshua Vasquez et al. · 2021 · Cell Reports
  15. Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
    Jan Van Elslande, Matthijs Oyaert, Natalie Lorent, Yannick Vande Weygaerde, Gijs Van Pottelbergh, Lode Godderis, Marc A. Van Ranst, Emmanuel André, Elizaveta Y. Padalko, Katrien Lagrou et al. · 2022 · Diagnostic Microbiology and Infectious Disease
  16. Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
    Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, Eng Eong Ooi, Rebecca Claire Harris, Clotilde El Guerche‐Séblain, Masoumeh Kisomi, Nabila Shaikh · 2023 · Infectious Diseases and Therapy
  17. Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemics
    Ricardo J. Aguas, Guilherme Gonçalves, Marcelo U. Ferreira, M. Gabriela M. Gomes · 2020 · medRxiv
  18. Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy
    Xia Li, Mi Shao, Xiangjun Zeng, Pengxu Qian, He Huang · 2021 · Signal Transduction and Targeted Therapy
  19. SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
    E. Scherer, A. Babiker, M. Adelman, B. Allman, A. Key, J. Kleinhenz, Rose M. Langsjoen, Phuong-Vi Nguyen, I. Onyechi, J. D. Sherman et al. · 2022 · New England Journal of Medicine
  20. COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals
    Rachel West, Amanda L. Kobokovich, N. Connell, G. Gronvall · 2020 · Trends in Microbiology
  21. Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation
    Brunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram, Dipankar Das, Narasimha Reddy Molugu, Sai D. Prasad, Srinivas V. Kannappa, Krishna M. Ella, Rajaram Ravikrishnan, Amit Awasthi et al. · 2021 · iScience
  22. COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis
    Lorenz Borsche, Bernd Glauner, Julian von Mendel · 2021 · Nutrients
  23. B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
    Dennis Lapuente, Thomas Winkler, Matthias Tenbusch · 2023 · Cellular and Molecular Immunology
  24. Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis
    Mohammad Ali Sahraian, Amirreza Azimi, Samira Navardi, Sara Ala, Abdorreza Naser Moghadasi · 2020 · Multiple Sclerosis and Related Disorders
  25. Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8 + T cell repertoire upon viral exposure
    Joshua M. Francis, Del Leistritz-Edwards, Augustine Dunn, Christina Tarr, Jesse W. Lehman, Conor Dempsey, Andrew Hamel, Violeta Rayon-Estrada, Gang Liu, Yuntong Wang et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
    Dufloo, Jérémy, Grzelak, Ludivine, Staropoli, Isabelle, Madec, Yoann, Tondeur, Laura, Anna, François, Pelleau, Stéphane, Wiedemann, Aurélie, Planchais, Cyril, Buchrieser, Julian et al. · 2021 · Cell Reports Medicine
  27. COVID-19: Does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics?
    Wim V. Damme, Ritwik Dahake, Remco van de Pas, Guido Vanham, Yibeltal Alemu Assefa · 2020 · Medical Hypotheses
  28. SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques
    Yashavanth Shaan Lakshmanappa, Sonny R. Elizaldi, Jamin W. Roh, B. Schmidt, Timothy D. Carroll, Kourtney D. Weaver, Justin C. Smith, A. Verma, J. Deere, Joseph C. Dutra et al. · 2021 · Nature Communications
  29. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
    Anthony T. DiPiazza, Sarah R. Leist, Olubukola M. Abiona, Juan I. Moliva, Anne P. Werner, Mahnaz Minai, Bianca M. Nagata, Kevin W. Bock, Emily Phung, Alexandra Schäfer et al. · 2021 · Immunity
  30. Identification of resident memory CD8 + T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue
    Julia Niessl, Takuya Sekine, Joshua Lange, Viktória Kónya, Marianne Forkel, Jovana Marić, Anna Rao, Luca Mazzurana, Efthymia Kokkinou, Whitney Weigel et al. · 2021 · Science Immunology
  31. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
    Thushan I. de Silva, Guihai Liu, Benjamin B. Lindsey, Danning Dong, Shona C. Moore, Sharon Nienyun Hsu, Dhruv R. Shah, Dannielle Wellington, Alexander J. Mentzer, Adrienn Angyal et al. · 2021 · iScience
  32. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
    Naranbhai, Vivek, Nathan, Anusha, Kaseke, Clarety, Berrios, Cristhian, Khatri, Ashok, Choi, Shawn, Getz, Matthew A., Tano-Menka, Rhoda, Ofoman, Onosereme, Gayton, Alton et al. · 2022 · Cell
  33. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
    Alina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde, Alexandra Kupke, Georgia Kalodimou, Leonard Limpinsel, Nisreen M.A. Okba, Berislav Bošnjak, Inga Sandrock, Ivan Odak et al. · 2021 · Proceedings of the National Academy of Sciences
  34. Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
    Annika Fendler, Lewis Au, Scott T.C. Shepherd, Fiona Byrne, Maddalena Cerrone, Laura Amanda Boos, Karolina Rzeniewicz, William Gordon, Benjamin Shum, Camille Lea Gerard et al. · 2021 · Nature Cancer
  35. Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
    Liyan Guo, Sheng Lin, Zimin Chen, Yu Cao, Bin He, Guangwen Lu · 2023 · Signal Transduction and Targeted Therapy
  36. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
    Magda Lourda, Majda Dzidic, Laura Hertwig, Helena Bergsten, Laura Marcela Palma Medina, Indranil Sinha, Egle Kvedaraite, Puran Chen, Jagadeeswara Rao Muvva, Jean‐Baptiste Gorin et al. · 2021 · Proceedings of the National Academy of Sciences
  37. Impaired function and delayed regeneration of dendritic cells in COVID-19
    Elena Winheim, Linus Rinke, Konstantin Lutz, A. Reischer, A. Leutbecher, L. Wolfram, Lisa Rausch, J. Kranich, P. R. Wratil, Johanna E. Huber et al. · 2021 · bioRxiv
  38. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases
    To Sing Fung, Ding Xiang Liu · 2021 · Annual Review of Microbiology
  39. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
    Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, Huitian Diao, Dewi Harjanto, Shirisha Meda, Krisann Marquart, Byron Koenitzer, Tracey E. Sciuto, Alexander Lobo et al. · 2023 · Cell
  40. Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns
    Baumgarth, Nicole, Nikolich-Žugich, Janko, Lee, F Eun-Hyung, Bhattacharya, Deepta · 2020 · The Journal of Immunology
  41. An Effective COVID-19 Vaccine Needs to Engage T Cells
    Karsten Sauer, Tim Harris · 2020 · Frontiers in Immunology
  42. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Mohammed Ahmed Garout, Ayman M. Al‐Qaaneh, Anupam Ashutosh Sule, Raghavendra Tirupathi, Abbas Saleh Al Mutair, Saad Alhumaid, Abdulkarim Hasan, Manish K. Dhawan et al. · 2021 · Pathogens
  43. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses
    Anusha Nathan, Elizabeth J. Rossin, Clarety Kaseke, Ryan Jin-hyung Park, Ashok Khatri, Dylan Koundakjian, Jonathan M. Urbach, Nishant Kumar Singh, Arman A. Bashirova, Rhoda Tano-Menka et al. · 2021 · Cell
  44. COVID-19 makes B cells forget, but T cells remember
    Cañete, Pablo F., Vinuesa, Carola G. · 2020 · Cell
  45. Innate lymphoid cell composition associates with COVID‐19 disease severity
    Marina García, Efthymia Kokkinou, Anna Carrasco García, Tiphaine Parrot, Laura Marcela Palma Medina, Kimia T. Maleki, Wanda Christ, Renata Varnaitė, Iva Filipovic, Hans‐Gustaf Ljunggren et al. · 2020 · Clinical & Translational Immunology
  46. Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19
    Juan Du, Lirong Wei, Guoli Li, Mingxi Hua, Yao Sun, Di Wang, Kai Han, Yonghong Yan, Chuan Song, Rui Song et al. · 2021 · Frontiers in Immunology
  47. Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination
    Norihide Jo, Yu Hidaka, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Masahiko Aoki, Masaki Yamamoto, Miki Nagao, Satoshi Morita, Takako Eguchi Nakajima et al. · 2023 · Nature Aging
  48. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
    Chen, Gui-Ling, Li, Xiao-Feng, Dai, Xia-Hong, Li, Nan, Cheng, Meng-Li, Huang, Zhen, Shen, Jian, Ge, Yu-Hua, Shen, Zhen-Wei, Deng, Yong-Qiang et al. · 2022 · The Lancet Microbe
  49. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses
    Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline C. Garliss, Laurene S. Cheung, Dilshad M. Choudhury, Jiajia Zhang, Luis Aparicio, Sadhana Bom, Rufiaat Rashid et al. · 2021 · Journal of Clinical Investigation
  50. A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters
    Yangtao Wu, Xiaofen Huang, Lunzhi Yuan, Shaojuan Wang, Yali Zhang, Hualong Xiong, Rirong Chen, Jian Ma, Ruoyao Qi, Meifeng Nie et al. · 2021 · Science Translational Medicine
  51. Point-of-care diagnostics: recent developments in a pandemic age
    Harshit Harpaldas, Siddarth Arumugam, Chelsey Campillo Rodriguez, Bhoomika Ajay Kumar, Vivian Yan Shi, Samuel K. Sia · 2021 · Lab on a Chip
  52. What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
    Marc K. Hellerstein · 2020 · Vaccine X
  53. Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
    Douglas C. Palmer, Beau R. Webber, Yogin K. Patel, Matthew J. Johnson, Christine M. Kariya, Walker S. Lahr, Maria R. Parkhurst, Jared J. Gartner, Todd D. Prickett, Frank J. Lowery et al. · 2022 · Med
  54. Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans
    Istvan T. Valyi-Nagy, Zsolt Matula, Márton Gönczi, Szabolcs Tasnády, Gabriella Bekő, Marienn Réti, Éva Ajzner, Ferenc Uher · 2021 · GeroScience
  55. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need
    Pengfei Jin, Jingxin Li, Hongxing Pan, Yanfei Wu, Fengcai Zhu · 2021 · Signal Transduction and Targeted Therapy
  56. Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients
    René Schramm, Angelika Costard‐Jäckle, Rasmus Rivinius, Bastian Fischer, Benjamin Z. Muller, Udo Boeken, Assad Haneya, Zdeněk Provazník, Cornelius Knabbe, Jan Fritz Gummert · 2021 · Clinical Research in Cardiology
  57. Immunity to SARS-CoV-2 up to 15 months after infection
    Harold Marcotte, Antonio Piralla, Fanglei Zuo, Likun Du, Irene Cassaniti, Hui Wan, Makiko Kumagai‐Braesch, Juni Andréll, Elena Percivalle, Josè Camilla Sammartino et al. · 2022 · iScience
  58. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2
    Woldemeskel, Bezawit A., Kwaa, Abena K., Garliss, Caroline C., Laeyendecker, Oliver, Ray, Stuart C., Blankson, Joel N. · 2020 · Journal of Clinical Investigation
  59. Transforming vaccinology
    Rino Rappuoli, Galit Alter, Bali Pulendran · 2024 · Cell
  60. T cells in COVID-19 — united in diversity
    Swadling, Leo, Maini, Mala K. · 2020 · Nature Immunology
  61. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding
    James R. Byrnes, Xin X. Zhou, Irene Lui, Susanna K. Elledge, Jeff E. Glasgow, Shion An Lim, Rita P. Loudermilk, Charles Y. Chiu, Taia T. Wang, Michael R. Wilson et al. · 2020 · mSphere
  62. COVID-19—Lessons Learned and Questions Remaining
    Ferric C. Fang, Constance Ann Benson, Carlos del Rı́o, Kathryn M. Edwards, Vance G. Fowler, David N. Fredricks, Ajit P. Limaye, Barbara E. Murray, Susanna Naggie, Peter G. Pappas et al. · 2020 · Clinical Infectious Diseases
  63. Multiscale PHATE identifies multimodal signatures of COVID-19
    Kuchroo, Manik, Huang, Jessie, Wong, Patrick, Grenier, Jean-Christophe, Shung, Dennis, Tong, Alexander, Lucas, Carolina, Klein, Jon, Burkhardt, Daniel B., Gigante, Scott et al. · 2022 · Nature Biotechnology
  64. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
    Srinivasa Reddy Bonam, Niranjan Goud Kotla, Raghvendra Ashok Bohara, Yury A. Rochev, Thomas Joseph Webster, Jagadeesh Bayry · 2020 · Nano Today
  65. Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection
    Xiao-Lin Jiang, Guo-Lin Wang, Xiang-Na Zhao, Fei-Hu Yan, Lin Yao, Z. Kou, Shengxiang Ji, Xiao-li Zhang, Cunbao Li, L. Duan et al. · 2021 · Nature Communications
  66. Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model
    Ami R. Patel, Jewell N. Walters, Emma L. Reuschel, Katherine Schultheis, Elizabeth M. Parzych, Ebony Nicole Gary, Igor Maricic, Mansi Purwar, Zeena Eblimit, Susanne N. Walker et al. · 2021 · Cell Reports Medicine
  67. Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders
    Céline Louapre, Michella Ibrahim, Élisabeth Maillart, Basma Abdi, Caroline Papeix, Bruno Stankoff, Anne‐Laure Dubessy, Caroline Bensa, Alain Créange, Zina Chamekh et al. · 2021 · Journal of Neurology Neurosurgery & Psychiatry
  68. T cell immunity to SARS-CoV-2
    Julia Niessl, Takuya Sekine, Marcus Buggert · 2021 · Seminars in Immunology
  69. Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection
    Rachel M. Gittelman, Enrico Lavezzo, Thomas M. Snyder, Harus Jabran Zahid, Cara L. Carty, Rebecca Elyanow, Sudeb C. Dalai, Ilan Richard Kirsch, Lance Baldo, Laura Manuto et al. · 2022 · JCI Insight
  70. A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
    Lim, Joey Ming Er, Hang, Shou Kit, Hariharaputran, Smrithi, Chia, Adeline, Tan, Nicole, Lee, Eng Sing, Chng, Edwin, Lim, Poh Lian, Young, Barnaby E., Lye, David Chien et al. · 2022 · Cell Reports Medicine
  71. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
    S. Nielsen, Line K. Vibholm, Ida Monrad, R. Olesen, Giacomo S. Frattari, M. H. Pahus, J. F. Højen, J. Gunst, C. Erikstrup, Andreas Holleufer et al. · 2020 · bioRxiv
  72. Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
    Soumya Jaganathan, Francis Stieber, Sonia N. Rao, Vladyslav Nikolayevskyy, Davide Manissero, Nadia P.C. Allen, Jeff Boyle, Jenny Howard · 2021 · Infectious Diseases and Therapy
  73. Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma
    Adolfo Aleman, Bhaskar Upadhyaya, Kevin Tuballes, Katerina Kappes, Charles Gleason, Katherine F. Beach, Sarita Agte, Komal Srivastava, Dalles Andre, A. Azad et al. · 2021 · Cancer Cell
  74. Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
    Yu Gao, Curtis Cai, David J. Wullimann, Julia Niessl, Olga Rivera‐Ballesteros, Puran Chen, Joshua L. Lange, Angélica Cuapio, Ola Blennow, Lotta Hansson et al. · 2022 · Immunity
  75. Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects
    Arash Arashkia, Somayeh Jalilvand, Nasir Mohajel, Atefeh Afchangi, Kayhan Azadmanesh, ‪Mostafa Salehi-Vaziri, Mehdi Fazlalipour, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Seyed Dawood Mousavi Nasab et al. · 2020 · Reviews in Medical Virology
  76. Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents
    Nina Koerber, Alina Priller, Sarah Yazici, T. Bauer, Cho-Chin Cheng, H. Mijočević, H. Wintersteller, S. Jeske, E. Vogel, M. Feuerherd et al. · 2022 · Nature Communications
  77. The role of CD4<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment
    Wang, Yifei, Zheng, Jingbin, Islam, Md Sahidul, Yang, Yang, Hu, Yuanjia, Chen, Xin · 2021 · International Journal of Biological Sciences
  78. Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with age
    Marion Humbert, Anna Olofsson, David Wullimann, Julia Niessl, Emma B. Hodcroft, Curtis Cai, Yu Gao, Ebba Sohlberg, Robert Dyrdak, Flora Mikaeloff et al. · 2023 · Proceedings of the National Academy of Sciences
  79. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
    Victoria Furer, Christien Rondaan, Nancy Agmon‐Levin, Sander van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Annette Ladefoged de Thurah, Ulf Müeller-Ladner, Daphna Paran, Karen Ingrid Schreiber et al. · 2021 · RMD Open
  80. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers
    Ricardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, Esther Dawen Yu, José Mateus, Lorenzo G. Quiambao, Eric W. Wang, Stephen A. Rawlings, Daniel Stadlbauer, Kaijun Jiang et al. · 2021 · The Journal of Infectious Diseases
  81. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
    Evangelos Andreakos, Laurent Abel, Donald Cuong Vinh, Elżbieta Kaja, Beth A. Drolet, Qian Zhang, Cliona O’Farrelly, Giuseppe Novelli, Carlos Rodríguez‐Gallego, Filomeen Haerynck et al. · 2021 · Nature Immunology
  82. Unique properties of tissue-resident memory T cells in the lungs: implications for COVID-19 and other respiratory diseases
    Francis R. Carbone · 2022 · Nature reviews. Immunology
  83. Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
    Seodhna M. Lynch, Guangran Guo, David S. Gibson, Anthony J. Bjourson, Taranjit Singh · 2021 · Cells
  84. Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID
    Kaiming Wang, Mobin Khoramjoo, Karthik K. Srinivasan, Paul M. K. Gordon, Rupasri Mandal, Dana Jackson, Wendy Sligl, Maria B. Grant, Josef Martin Penninger, Christoph H. Borchers et al. · 2023 · Cell Reports Medicine
  85. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
    Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, Adriano Giorgio Rossi, Nicole Brace, Paul Aidan Cahill, Sandra M MacRury, Jun Wei, Ian L. Megson · 2021 · Frontiers in Cardiovascular Medicine
  86. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection
    Candice Clarke, Maria F. Prendecki, Amrita Dhutia, Jaslyn Ju Lia Gan, Claire Edwards, Virginia Prout, Liz Lightstone, Eleanor L. Parker, Federica Marchesin, Megan E. Griffith et al. · 2021 · Kidney International
  87. Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection
    Yao Lin, Guolin Wang, Yuan Shen, Zhuang-Ye Wang, Bing-Dong Zhan, Li‐Jun Duan, Bing Lu, Chao Shi, Yumeng Gao, Hong-Hong Peng et al. · 2021 · The Journal of Infectious Diseases
  88. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
    Delia Goletti, Linda Petrone, Davide Manissero, Antonio Bertoletti, Sonia N. Rao, Nduku Ndunda, Alessandro Sette, Vladyslav Nikolayevskyy · 2021 · Clinical Microbiology and Infection
  89. Profiling CD8+ T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants
    Hang Zhang, Shasha Deng, Liting Ren, Peiyi Zheng, Xiaowen Hu, Tengchuan Jin, Xu Tan · 2021 · Cell Reports
  90. The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
    Antonio Bertoletti, Anthony Tanoto Tan, Nina Le Bert · 2021 · Oxford Open Immunology
  91. SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy
    Marco Vinceti, Tommaso Filippini, Kenneth Jay Rothman, Silvia Di Federico, Nicola Orsini · 2021 · Environmental Research
  92. Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults
    Jin Young Ahn, Jeongsoo Lee, You Suk Suh, Young Goo Song, Yoon-Jeong Choi, Kyoung Hwa Lee, Sang Hwan Seo, Manki Song, Jong‐Won Oh, Minwoo Kim et al. · 2022 · The Lancet Microbe
  93. Are we underestimating seroprevalence of SARS-CoV-2?
    Stephen Burgess, Mark Ponsford, Dipender Gill · 2020 · BMJ
  94. Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic
    Ganna Rozhnova, Christiaan Hendrik van Dorp, Patricia C.J.L. Bruijning-Verhagen, Martin Bootsma, Janneke H. H. M. van de Wijgert, Marc J. M. Bonten, Mirjam Kretzschmar · 2021 · Nature Communications
  95. Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform
    Ahmed Abdul Quadeer, Syed Faraz Ahmed, Matthew R. McKay · 2021 · Cell Reports Medicine
  96. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
    Aneesh Chandran, Joshua Rosenheim, Gayathri Nageswaran, Leo Swadling, Gabriele Pollara, Rishi K Gupta, Alice R. Burton, José Afonso Guerra‐Assunção, Annemarie Woolston, Tahel Ronel et al. · 2022 · Cell Reports Medicine
  97. Adaptive immunity to SARS-CoV-2 infection: A systematic review
    Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, Luana Nepomuceno Gondim Costa Lima · 2022 · Frontiers in Immunology
  98. Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
    Ali Hamady, JinJu Lee, Zuzanna Loboda · 2021 · Infection
  99. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
    Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Francesco Annunziato, Lorenzo Cosmi · 2021 · Seminars in Immunology
  100. Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
    Hassen Kared, Asia‐Sophia Wolf, Amin Alirezaylavasani, Anthony Ravussin, Guri Solum, Trung The Tran, Fridtjof Lund‐Johansen, John Torgils Vaage, Lise Sofie Haug Nissen‐Meyer, Unni Cecilie Nygaard et al. · 2022 · Nature Communications